Prospect News: News for Laboratoire Eimer

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with L > Issuers starting with L, HY only > All stories on Laboratoire Eimer > Stories on Laboratoire Eimer, HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Laboratoire Eimer

4/5/2024	BKDDHY	Moody’s lowers Laboratoire Eimer
7/6/2021	BKHY	Moody's changes Biogroup view to stable
1/29/2021	HY	New Issue: Laboratoire Eimer, CAB sell €1.05 billion of seven-, eight-year notes
1/28/2021	HY	Laboratoire Eimer, CAB to sell €1 billion of seven-, eight-year notes
1/26/2021	HY	France’s Biogroup marketing €1 billion two-part notes offering through Wednesday
1/25/2021	BKDDHY	S&P rates CAB notes B-
1/25/2021	BKDDHY	Moody's gives CAB notes B2
1/25/2021	BKHY	Fitch gives Laboratoire Eimer notes CCC+

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.